Publication | Open Access
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
13
Citations
44
References
2024
Year
ClinicalTrials.gov Identifier: NCT03409198.
| Year | Citations | |
|---|---|---|
Page 1
Page 1